88 related articles for article (PubMed ID: 33244281)
1. Combined Detection of ACTN4 and SCC-Ag is a Promising Serological Biomarker for Cervical Intraepithelial Neoplasia 3 or Worse: A Case-Control Study.
Zhu B; Dong B; Hong S; Wang M; Dai W; Zheng Q; Wu D; Cao Y
Risk Manag Healthc Policy; 2020; 13():2677-2687. PubMed ID: 33244281
[TBL] [Abstract][Full Text] [Related]
2. Serum Actinin-4 Levels as a Potential Diagnostic and Prognostic Marker in Cervical Cancer.
Ma X; Xue H; Zhong J; Feng B; Zuo Y
Dis Markers; 2020; 2020():5327378. PubMed ID: 32855746
[TBL] [Abstract][Full Text] [Related]
3. CTHRC1 as a novel biomarker in the diagnosis of cervical squamous cell carcinoma.
Xu G; Fan W; Wang F; Lu H; Xing X; Zhang R; Jiang P
Int J Clin Exp Pathol; 2018; 11(2):847-854. PubMed ID: 31938174
[TBL] [Abstract][Full Text] [Related]
4. A study on the clinical value of
Qi C; He S; Cai L; Zhang L; Ding H; Chen Y
Oncol Lett; 2021 Nov; 22(5):746. PubMed ID: 34539850
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Value of Albumin to Fibrinogen Ratio in Cervical Cancer.
Huang L; Mo Z; Zhang L; Qin S; Qin S; Li S
Int J Biol Markers; 2020 Jun; 35(2):66-73. PubMed ID: 32389031
[TBL] [Abstract][Full Text] [Related]
6. ROC-Analysis Derived Immunohistochemical P53 Cut-Off Scores as an Adjunct to Routine Histopathology for Better Diagnostic Compartmentalisation of Cervical Lesions.
Shukla A; Sachan R; Maurya M; Patel ML; Sankhwar P
Int J Appl Basic Med Res; 2022; 12(3):177-184. PubMed ID: 36131854
[TBL] [Abstract][Full Text] [Related]
7. Highly expressed circ_0000285 from serum and cervical exfoliated cells as a novel biomarker for the diagnosis of early stage-cervical cancer.
Chen H; Tian X; Luan Y; Lu H
J Obstet Gynaecol; 2023 Dec; 43(1):2196344. PubMed ID: 37029728
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic accuracy of cervical cancer screening and screening-triage strategies among women living with HIV-1 in Burkina Faso and South Africa: A cohort study.
Kelly HA; Chikandiwa A; Sawadogo B; Gilham C; Michelow P; Lompo OG; Omar T; Zan S; Magooa P; Segondy M; Nagot N; Meda N; Delany-Moretlwe S; Mayaud P;
PLoS Med; 2021 Mar; 18(3):e1003528. PubMed ID: 33661957
[TBL] [Abstract][Full Text] [Related]
9. Clinical Value of Combining
Sookha RR; Zhi W; Shen Y; Lazare C; Wang L; Meng Y; Cao C; Hu J; Wu P
J Cancer; 2018; 9(17):3101-3108. PubMed ID: 30210633
[No Abstract] [Full Text] [Related]
10. Predictive value of preoperative serum squamous cell carcinoma antigen (SCC-Ag) level on tumor recurrence in cervical squamous cell carcinoma patients treated with radical surgery: A single-institution study.
Guo Q; Zhu J; Wu Y; Wen H; Xia L; Wu X; Ju X
Eur J Surg Oncol; 2020 Jan; 46(1):131-138. PubMed ID: 31481274
[TBL] [Abstract][Full Text] [Related]
11. Serum miR-638 Combined with Squamous Cell Carcinoma-Related Antigen as Potential Screening Biomarkers for Cervical Squamous Cell Carcinoma.
Zheng S; Li R; Liang J; Wen Z; Huang X; Du X; Dong S; Zhu K; Chen X; Liu D; Wu J; Liu Y; Zou X; Wang Y; Li J; Zeng F; Feng L; Yang G; Jing C
Genet Test Mol Biomarkers; 2020 Apr; 24(4):188-194. PubMed ID: 32216635
[No Abstract] [Full Text] [Related]
12. Correlation Between Squamous Cell Carcinoma Antigen Level and the Clinicopathological Features of Early-Stage Cervical Squamous Cell Carcinoma and the Predictive Value of Squamous Cell Carcinoma Antigen Combined With Computed Tomography Scan for Lymph Node Metastasis.
Xu D; Wang D; Wang S; Tian Y; Long Z; Ren X
Int J Gynecol Cancer; 2017 Nov; 27(9):1935-1942. PubMed ID: 28914639
[TBL] [Abstract][Full Text] [Related]
13. Significance of elevated SCC-Ag level on tumor recurrence and patient survival in patients with squamous-cell carcinoma of uterine cervix following definitive chemoradiotherapy: a multi-institutional analysis.
Choi KH; Lee SW; Yu M; Jeong S; Lee JW; Lee JH
J Gynecol Oncol; 2019 Jan; 30(1):e1. PubMed ID: 30479085
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of squamous cell carcinoma antigen for predicting tumor recurrence in cervical squamous cell carcinoma patients.
Ryu HK; Baek JS; Kang WD; Kim SM
Obstet Gynecol Sci; 2015 Sep; 58(5):368-76. PubMed ID: 26430661
[TBL] [Abstract][Full Text] [Related]
15. Human Plasma Levels of Vascular Endothelial Growth Factor, Matrix Metalloproteinase 9, and Tissue Inhibitor of Matrix Metalloproteinase 1 and Their Applicability as Tumor Markers in Diagnoses of Cervical Cancer Based on ROC Analysis.
Zajkowska M; Zbucka-Krętowska M; Sidorkiewicz I; Lubowicka E; Będkowska GE; Gacuta E; Szmitkowski M; Ławicki S
Cancer Control; 2018; 25(1):1073274818789357. PubMed ID: 30037277
[TBL] [Abstract][Full Text] [Related]
16. Actinin-4 as a Diagnostic Biomarker in Serum of Breast Cancer Patients.
Fang C; Li JJ; Deng T; Li BH; Geng PL; Zeng XT
Med Sci Monit; 2019 May; 25():3298-3302. PubMed ID: 31054253
[TBL] [Abstract][Full Text] [Related]
17. Serum expression level of squamous cell carcinoma antigen, highly sensitive C-reactive protein, and CA-125 as potential biomarkers for recurrence of cervical cancer.
Guo S; Yang B; Liu H; Li Y; Li S; Ma L; Liu J; Guo W
J Cancer Res Ther; 2017; 13(4):689-692. PubMed ID: 28901315
[TBL] [Abstract][Full Text] [Related]
18. miR-152 may function as an early diagnostic and prognostic biomarker in patients with cervical intraepithelial neoplasia and patients with cervical cancer.
Yang D; Zhang Q
Oncol Lett; 2019 Jun; 17(6):5693-5698. PubMed ID: 31186794
[TBL] [Abstract][Full Text] [Related]
19. Can serial evaluation of serum SCC-Ag-level predict tumor recurrence and patient survival in squamous-cell carcinoma of uterine cervix treated with definitive chemoradiotherapy? A multi-institutional analysis.
Choi KH; Yu M; Jeong S; Lee JH
Int J Clin Oncol; 2020 Jul; 25(7):1405-1411. PubMed ID: 32221801
[TBL] [Abstract][Full Text] [Related]
20. The Validity of Using Human Squamous Cell Carcinoma Associated Antigen and Cytokeratin 19 Fragment Antigen 21-1 to Predict Postoperative Adjuvant Radiotherapy for Nonbulky Early-Stage Squamous Cell Carcinoma of the Cervix.
Liu CZ; Zeng HX; Zhao JJ; Rong Y; Mo ZL; Li LA; Zhang JQ
Int J Gynecol Cancer; 2017 Jun; 27(5):994-1000. PubMed ID: 28498239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]